PEP07 Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
Acute Myeloid LeukemiaLymphoma, Mantle-Cell
PharmaEngine32 enrolled5 locationsNCT05659732
Recruiting
Phase 1
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors
Advanced Solid TumorMetastatic Solid Tumor
PharmaEngine54 enrolled3 locationsNCT05983523